1. Home
  2. XENE vs EXPO Comparison

XENE vs EXPO Comparison

Compare XENE & EXPO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

XENE

Xenon Pharmaceuticals Inc.

HOLD

Current Price

$58.56

Market Cap

3.2B

Sector

Health Care

ML Signal

HOLD

Logo Exponent Inc.

EXPO

Exponent Inc.

HOLD

Current Price

$65.07

Market Cap

3.4B

ML Signal

HOLD

Company Overview

Basic Information
Metric
XENE
EXPO
Founded
1996
1967
Country
Canada
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Professional Services
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
3.2B
3.4B
IPO Year
2014
1996

Fundamental Metrics

Financial Performance
Metric
XENE
EXPO
Price
$58.56
$65.07
Analyst Decision
Strong Buy
Buy
Analyst Count
12
3
Target Price
$67.17
$88.00
AVG Volume (30 Days)
1.1M
440.8K
Earning Date
05-11-2026
04-30-2026
Dividend Yield
N/A
1.90%
EPS Growth
N/A
N/A
EPS
N/A
2.07
Revenue
$311,000.00
$582,014,000.00
Revenue This Year
N/A
$12.75
Revenue Next Year
$2,436.26
$8.50
P/E Ratio
N/A
$31.60
Revenue Growth
N/A
4.21
52 Week Low
$28.19
$63.25
52 Week High
$62.91
$83.92

Technical Indicators

Market Signals
Indicator
XENE
EXPO
Relative Strength Index (RSI) 65.00 41.47
Support Level $39.93 $64.33
Resistance Level $59.44 $73.62
Average True Range (ATR) 1.86 1.87
MACD -0.17 0.24
Stochastic Oscillator 80.01 48.48

Price Performance

Historical Comparison
XENE
EXPO

About XENE Xenon Pharmaceuticals Inc.

Xenon Pharmaceuticals Inc is a neuroscience-focused biopharmaceutical company committed to improving the lives of people living with neurological and psychiatric disorders. It is advancing a novel product pipeline to address areas of high unmet medical need, including epilepsy and depression. The product candidates of the group include XEN1101, NBI-921352, and XEN496 for Epilepsy and Nav1.7 oral inhibitors for Pain.

About EXPO Exponent Inc.

Exponent Inc is a science and engineering consulting firm that provides solutions to complex problems. The company's consultant team is composed of scientists, physicians, engineers, as well as business and regulatory consultants. The company currently operates through two segments. The engineering and other scientific segments, which account for the majority of revenue, provide servicing encompassing biomechanics, biomedical engineering, buildings and structures, civil engineering, construction consulting, etc. The environmental and health segment covers chemical regulation and food safety, ecological and biological sciences, environmental and earth sciences and others. The company generates almost all of its revenues from America.

Share on Social Networks: